Gastroesophageal Cancer | Norton Healthcare

Indication: Gastroesophageal Cancer

A Phase II study of cytoreduction, gastrectomy, and hyperthermic intraperitoneal chemoperfusion (HIPEC) in patients with gastric adenocarcinoma and carcinomatosis or positive cytology

Sub-indication: Gastroesophageal Cancer


Principal Investigator: Michael Egger, M.D.
University of Louisville Physicians - Surgical Oncology

Sponsor: UofL Investigator

Learn more at

Email for more information:

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.